TY - JOUR
T1 - MiR-33 contributes to the regulation of cholesterol homeostasis
AU - Rayner, Katey J.
AU - Suárez, Yajaira
AU - Dávalos, Alberto
AU - Parathath, Saj
AU - Fitzgerald, Michael L.
AU - Tamehiro, Norimasa
AU - Fisher, Edward A.
AU - Moore, Kathryn J.
AU - Fernández-Hernando, Carlos
PY - 2010/6/18
Y1 - 2010/6/18
N2 - Cholesterol metabolism is tightly regulated at the cellular level. Here we show that miR-33, an intronic microRNA (miRNA) located within the gene encoding sterol-regulatory element-binding factor-2 (SREBF-2), a transcriptional regulator of cholesterol synthesis, modulates the expression of genes involved in cellular cholesterol transport. In mouse and human cells, miR-33 inhibits the expression of the adenosine triphosphate-binding cassette (ABC) transporter, ABCA1, thereby attenuating cholesterol efflux to apolipoprotein A1. In mouse macrophages, miR-33 also targets ABCG1, reducing cholesterol efflux to nascent high-density lipoprotein (HDL). Lentiviral delivery of miR-33 to mice represses ABCA1 expression in the liver, reducing circulating HDL levels. Conversely, silencing of miR-33 in vivo increases hepatic expression of ABCA1 and plasma HDL levels. Thus, miR-33 appears to regulate both HDL biogenesis in the liver and cellular cholesterol efflux. Copyright Science 2010 by the American Association for the Advancement of Science; all rights reserved.
AB - Cholesterol metabolism is tightly regulated at the cellular level. Here we show that miR-33, an intronic microRNA (miRNA) located within the gene encoding sterol-regulatory element-binding factor-2 (SREBF-2), a transcriptional regulator of cholesterol synthesis, modulates the expression of genes involved in cellular cholesterol transport. In mouse and human cells, miR-33 inhibits the expression of the adenosine triphosphate-binding cassette (ABC) transporter, ABCA1, thereby attenuating cholesterol efflux to apolipoprotein A1. In mouse macrophages, miR-33 also targets ABCG1, reducing cholesterol efflux to nascent high-density lipoprotein (HDL). Lentiviral delivery of miR-33 to mice represses ABCA1 expression in the liver, reducing circulating HDL levels. Conversely, silencing of miR-33 in vivo increases hepatic expression of ABCA1 and plasma HDL levels. Thus, miR-33 appears to regulate both HDL biogenesis in the liver and cellular cholesterol efflux. Copyright Science 2010 by the American Association for the Advancement of Science; all rights reserved.
UR - http://www.scopus.com/inward/record.url?scp=77953787211&partnerID=8YFLogxK
U2 - 10.1126/science.1189862
DO - 10.1126/science.1189862
M3 - Article
C2 - 20466885
AN - SCOPUS:77953787211
SN - 0036-8075
VL - 328
SP - 1570
EP - 1573
JO - Science
JF - Science
IS - 5985
ER -